alzheimers.global-summit.comDementia Conferences | Alzheimers Disease Conferences | Dementia Congress 2023 | World Dementia Con

ferences Toggle navigation MENU Alzheimer’s 2023 HomeJournals A-Z Journals Browse by Subject Newly Launched Journals Open Access Conferences Upcoming Conferences Previous Conferences Past Conferences Reports Abstract Registration Technical Program Symposium & Contact Details Scientific Program Call for Abstracts Brochure & Contact Details Organizing Committee Poster Submission Speaker Guidelines & FAQs Terms & Conditions B2B Venue & Hospitality Sponsors / Exhibitors Sponsors Exhibition Our Supporters 2024 Supporters 2023 Supporters 2022 Supporters 2021 Supporters 2020 Supporters 2019 Supporters 2018 Supporters 2017 Supporters 2016 Supporters 2015 Supporters 2014 Supporters 2013 Supporters 2012 Supporters 2011 Supporters Awards Research Excellence Awards Poster Presentation Young Researchers Forum ePoster Presentation 18 th World Summit on Alzheimer’s Disease, Dementia Care Research and Awareness July 31-August 01, 2023 Rome, Italy Submit Abstract Register Now Sessions & Tracks Program Schedule Reader Base Awards Nomination Market Analysis Search 1000+ Events Abstract Submission Registration Organizing Committee Conference Brochure Sessions & Tracks Scientific Program Meet Inspiring Speakers and Experts at our 3000+ Global Events with over 1000+ Conferences, 1000+ Symposiums and 1000+ Workshops on Medical, Pharma, Engineering, Science, Technology and Business. Explore and learn more about Conference Series : World’s leading Event Organizer Conference Series Conferences gaining more Readers and Visitors Conference Series Web Metrics at a Glance 3000+ Global Events 100 Million+ Visitors 75000+ Unique visitors per conference 100000+ Page views for every individual conference Unique Opportunity! Online visibility to the Speakers and Experts abstracts@europeconferences.com registrations@europeconferences.com contact@europeconferences.com abstracts@europeconferences.com registrations@europeconferences.com contact@europeconferences.com Recommended Global Neuroscience Webinars & Conferences Europe & UK Asia Pacific & Middle East Canada Alzheimer’s 2023 About Conference Session / Tracks Market Analysis Past conference report About Conference We Welcome you for 18 th World Summit on Alzheimer’s Disease, Dementia Care Research and Awareness which is going to be held on July 31-August 01, 2023 Rome, Italy The Alzheimer’s disease is currently ranked as the sixth leading cause of death in the United States, but recent estimates indicate that the disorder may rank third, just behind heart disease and cancer, as a cause of death for older people. Alzheimer’s is the most common cause of dementia among older adults. Dementia is the loss of cognitive functioning—thinking, remembering, and reasoning—and behavioral abilities to such an extent that it interferes with a person’s daily life and activities. Dementia ranges in severity from the mildest stage, when it is just beginning to affect a person’s functioning, to the most severe stage, when the person must depend completely on others for basic activities of daily living. The causes of dementia can vary, depending on the types of brain changes that may be taking place. Other dementias include Lewy body dementia , frontotemporal disorders , and vascular dementia . It is common for people to have mixed dementia —a combination of two or more types of dementia. For example, some people have both Alzheimer’s disease and vascular dementia. Alzheimer’s disease is named after Dr. Alois Alzheimer. In 1906, Dr. Alzheimer noticed changes in the brain tissue of a woman who had died of an unusual mental illness. Her symptoms included memory loss, language problems, and unpredictable behavior. After she died, he examined her brain and found many abnormal clumps (now called amyloid plaques) and tangled bundles of fibers (now called neurofibrillary, or tau, tangles). These plaques and tangles in the brain are still considered some of the main features of Alzheimer’s disease. Another feature is the loss of connections between nerve cells (neurons) in the brain. Neurons transmit messages between different parts of the brain, and from the brain to muscles and organs in the body. Young Scientist Benefits: Our conferences provide best Platform for your research through oral presentations. Share the ideas with both eminent researchers and mentors. Young Scientist Award reorganization certificate and memento to the winners Young Scientists will get appropriate and timely information by this Forum. Platform for collaboration among young researchers for better development. Award should motivate participants to strive to realize their full potential which could in turn be beneficial to the field as whole. Session / Tracks Session on Alzheimer’s Disease Causes , Diagnosis and Prevention Alzheimer’s can be defined as a gradually progressive neurodegenerative disease characterized of memory impairment and subsequent disturbances in personality, mood, reasoning and perception. It caused by a combination of lifestyle, genetic, and environmental factors that gradually impairs the brain. It can be diagnosed by evaluating subject’s medical history, testing mental and mood status (NINCDS-ADRDA), lab tests and brain scans. An ongoing clinical trial conducted by Dominantly Inherited Alzheimer Network (DIAN), is to test whether antibodies to beta-amyloid can reduce the accumulation of beta-amyloid plaque in the brains with such genetic mutations and thereby reduce, delay or prevent symptoms and it can also be impeded by choosing the diet carefully. Session on Alzheimer’s disease Pathogenesis and mechanisms Beta amyloid plaques and Neurofibrillary tangles of tau protein Pathology are prime suspects of neuronal cell death in Alzheimer’s it caused by accumulation of abnormally folded A-beta and tau proteins and Plaques of small peptides 39–43 amino acids to form Beta-amyloid which comprises amyloid precursor protein (APP) and a transmembrane protein that pierce the neuron’s membrane. It later forms a fibrils of amyloid protein clump which get deposited in neurons to form a dense senile plaques , amyloid fibrils disrupts the cell’s calcium ions homeostasis and induces apoptosis of neurons which results in neurodegeneration affecting brain functioning. Session on Clinical Trials on Alzheimer’s disease More than 400 clinical trials are presently looking at new treatments for Alzheimer’s disease (AD) and many of them are actively recruiting. Many of the researches are based on decreasing the toxic effects of amyloid-beta in the brain, targeting amyloid production, blocking the accumulation of amyloid-beta into plaques , Aiming at Tau, Improving Cognition with Serotonin and Dietary Supplements . Session on Vascular dementia Vascular dementia is the wider term for dementia associated with brain damage from impaired blood flow to the brain. The various types of dementia are Single-infarct , Multi-infarct dementia , Subcortical vascular dementia ( Binswanger’s disease ), and Mixed dementia . Its clinical symptoms are Problems with planning or organising, concentrating, including short periods of sudden confusion and Memory, language and visuospatial skills also get affected . Anyone can be affected by Vascular dementia , but several factors increase the risk. These include: High blood pressure , Smoking , Diabetes , High cholesterol , History of mild warning strokes , Evidence of disease in arteries elsewhere and Heart rhythm abnormalities , while no remedy can reverse the damage that has already been occurred, treatment to prevent extra strokes may be very essential. Session on Ageing and Gerontology Gerontology is scientific study of aging process and concerned with physical, mental , and social aspects and implications of aging. The field of gerontology is actually quite broader, containing many professionals who focus on different aspects of aging and development. Gerontologists include practitioners and researchers in the areas fields of nursing ,...